These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33182840)

  • 41. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
    BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circular RNAs in Gastric Cancer: Potential Biomarkers and Therapeutic Targets.
    Ouyang J; Long Z; Li G
    Biomed Res Int; 2020; 2020():2790679. PubMed ID: 32685459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer.
    Zhao Z; Zhang C; Zhao Q
    Scand J Gastroenterol; 2020 Mar; 55(3):338-346. PubMed ID: 32172630
    [No Abstract]   [Full Text] [Related]  

  • 44. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
    Chen X; Lin Z; Xue M; Si J; Chen S
    PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.
    Le Y; Zhou Y; Iribarren P; Wang J
    Cell Mol Immunol; 2004 Apr; 1(2):95-104. PubMed ID: 16212895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of chemokine and chemokine receptors in head and neck squamous cell carcinoma: A critical review.
    da Silva JM; Soave DF; Moreira Dos Santos TP; Batista AC; Russo RC; Teixeira MM; da Silva TA
    Oral Oncol; 2016 May; 56():8-16. PubMed ID: 27086481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemokines in tumor proximal fluids.
    Kotyza J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):41-49. PubMed ID: 28115749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An expanding appreciation of the role chemokine receptors play in cancer progression.
    Howard OM; Galligan CL
    Curr Pharm Des; 2004; 10(19):2377-89. PubMed ID: 15279615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
    Kraaijeveld AO; de Jager SC; van Berkel TJ; Biessen EA; Jukema JW
    Curr Pharm Des; 2007; 13(10):1039-52. PubMed ID: 17430167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
    Gao J; Cao R; Mu H
    Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
    Shekari N; Baradaran B; Shanehbandi D; Kazemi T
    Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in Molecular Biomarkers for Gastric Cancer.
    Zheng TH; Zhao JL; Guleng B
    Crit Rev Eukaryot Gene Expr; 2015; 25(4):299-305. PubMed ID: 26559090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
    Mu YP; Sun WJ; Lu CW; Su XL
    Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemokines and their receptors: orchestrating a fine balance between health and disease.
    Sharma M
    Crit Rev Biotechnol; 2010 Mar; 30(1):1-22. PubMed ID: 19780653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
    Gambardella V; Castillo J; Tarazona N; Gimeno-Valiente F; Martínez-Ciarpaglini C; Cabeza-Segura M; Roselló S; Roda D; Huerta M; Cervantes A; Fleitas T
    Cancer Treat Rev; 2020 Jun; 86():102015. PubMed ID: 32248000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemokines network in bone metastasis: Vital regulators of seeding and soiling.
    Sharma G; Pothuraju R; Kanchan RK; Batra SK; Siddiqui JA
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):457-472. PubMed ID: 35124194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemokines in tumor progression and metastasis.
    Sarvaiya PJ; Guo D; Ulasov I; Gabikian P; Lesniak MS
    Oncotarget; 2013 Dec; 4(12):2171-85. PubMed ID: 24259307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.